29 February 2024 false No description of principal activity Taxfiler 2024.6 14637922business:PrivateLimitedCompanyLtd2024-02-292025-02-28 146379222024-02-28 146379222024-02-292025-02-28 14637922business:AuditExempt-NoAccountantsReport2024-02-292025-02-28 14637922business:FilletedAccounts2024-02-292025-02-28 146379222025-02-28 14637922business:Director12024-02-292025-02-28 14637922business:Director22024-02-292025-02-28 14637922business:RegisteredOffice2024-02-292025-02-28 146379222024-02-28 14637922core:WithinOneYear2025-02-28 14637922core:WithinOneYear2024-02-28 14637922core:ShareCapitalcore:PreviouslyStatedAmount2025-02-28 14637922core:ShareCapitalcore:PreviouslyStatedAmount2024-02-28 14637922core:SharePremiumcore:PreviouslyStatedAmount2025-02-28 14637922core:SharePremiumcore:PreviouslyStatedAmount2024-02-28 14637922core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-02-28 14637922core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-02-28 14637922core:PreviouslyStatedAmount2025-02-28 14637922core:PreviouslyStatedAmount2024-02-28 14637922business:SmallEntities2024-02-292025-02-28 14637922countries:EnglandWales2024-02-292025-02-28 14637922core:IntangibleAssetsOtherThanGoodwill2024-02-28 14637922core:IntangibleAssetsOtherThanGoodwill2024-02-292025-02-28 14637922core:IntangibleAssetsOtherThanGoodwill2025-02-28 146379222023-02-032024-02-28 iso4217:GBP xbrli:pure
Company Registration No. 14637922 (England and Wales)
Asclepius Medtech Ltd Unaudited accounts for the period from 29 February 2024 to 28 February 2025
Asclepius Medtech Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Asclepius Medtech Ltd Company Information for the period from 29 February 2024 to 28 February 2025
Directors
Ramanan Wigneswaran Mylvaganam Michael Anthony Morgan-Curran
Company Number
14637922 (England and Wales)
Registered Office
12 King Street Leeds LS1 2HL England
- 3 -
Asclepius Medtech Ltd Statement of financial position as at 28 February 2025
2025 
2024 
Notes
£ 
£ 
Called up share capital not paid
- 
6 
Fixed assets
Intangible assets
4
146,778 
43,450 
Current assets
Debtors
5
17,567 
7,078 
Cash at bank and in hand
38,654 
109,132 
56,221 
116,210 
Creditors: amounts falling due within one year
6
(212,369)
(188,978)
Net current liabilities
(156,148)
(72,768)
Net liabilities
(9,370)
(29,312)
Capital and reserves
Called up share capital
1 
6 
Share premium
15,000 
- 
Profit and loss account
(24,371)
(29,318)
Shareholders' funds
(9,370)
(29,312)
For the period ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 27 October 2025 and were signed on its behalf by
Michael Anthony Morgan-Curran Director Company Registration No. 14637922
- 4 -
Asclepius Medtech Ltd Notes to the Accounts for the period from 29 February 2024 to 28 February 2025
1
Statutory information
Asclepius Medtech Ltd is a private company, limited by shares, registered in England and Wales, registration number 14637922. The registered office is 12 King Street, Leeds, LS1 2HL, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous period, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Other 
£ 
Cost
At 29 February 2024
43,450 
Additions
103,328 
At 28 February 2025
146,778 
Amortisation
At 29 February 2024
- 
At 28 February 2025
- 
Net book value
At 28 February 2025
146,778 
At 28 February 2024
43,450 
5
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
VAT
17,567 
- 
Trade debtors
- 
3,567 
Accrued income and prepayments
- 
3,511 
17,567 
7,078 
- 5 -
Asclepius Medtech Ltd Notes to the Accounts for the period from 29 February 2024 to 28 February 2025
6
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Trade creditors
32,158 
104 
Other creditors
138,884 
132,270 
Loans from directors
5,010 
18,947 
Accruals
650 
1,990 
Deferred income
35,667 
35,667 
212,369 
188,978 
7
Average number of employees
During the period the average number of employees was 0 (2024: 0).
- 6 -